Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05450744
Title 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Telix International Pty Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries NZL | NLD | AUT | AUS


No variant requirements are available.